QIPT
Quipt Home Medical Corp.
Medical - Devices
Market Cap$161M
5Y Perf.-3.4%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
QIPT vs DBVT
Revenue, margins, valuation, and 5-year total return — side by side.
DBVT
DBV Technologies S.A.
Biotechnology
Market Cap$1712.35T
5Y Perf.-56.7%
QIPT vs DBVT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | QIPT | DBVT |
|---|---|---|
| Industry | Medical - Devices | Biotechnology |
| Market Cap | $161M | $1712.35T |
| Revenue (TTM) | $287M | $0.00 |
| Net Income (TTM) | $-11M | $-168M |
| Gross Margin | 84.5% | — |
| Operating Margin | -0.8% | — |
| Total Debt | $119M | $22M |
| Cash & Equiv. | $13M | $194M |
QIPT vs DBVT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
QIPT
DBVT
| Stock | May 20 | Mar 26 | Return |
|---|---|---|---|
| Quipt Home Medical … (QIPT) | 100 | 96.6 | -3.4% |
| DBV Technologies S.… (DBVT) | 100 | 43.3 | -56.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: QIPT vs DBVT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: DBVT leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Quipt Home Medical Corp. is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. As sector peers, any of these can serve as alternatives in the same allocation.
QIPT
Quipt Home Medical Corp.
The Growth Play
QIPT is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth -0.2%, EPS growth -56.3%, 3Y rev CAGR 20.6%
- 351.7% 10Y total return vs DBVT's -87.0%
- -0.2% revenue growth vs DBVT's -100.0%
Best for: growth exposure and long-term compounding
DBVT
DBV Technologies S.A.
The Defensive Pick
DBVT carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 1.26, Low D/E 12.8%, current ratio 3.67x
- Beta 1.26, current ratio 3.67x
- 0.3% margin vs QIPT's -3.7%
Best for: sleep-well-at-night and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | QIPT | -0.2% revenue growth vs DBVT's -100.0% |
| Quality / Margins | DBVT | 0.3% margin vs QIPT's -3.7% |
| Stability / Safety | DBVT | Lower D/E ratio (12.8% vs 106.0%) |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | DBVT | +110.4% vs QIPT's +70.6% |
| Efficiency (ROA) | QIPT | -5.3% ROA vs DBVT's -89.0% |
QIPT vs DBVT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLQIPTLAGGINGDBVT
DBVTDBV Technologies S.A.
2leads
QIPTQuipt Home Medical Co…
2leads
6 Total Categories
CATEGORYLEADERvs DBVTMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
DBVT1/1
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
QIPT4/7
Total Returns1Y, 3Y, 5Y total returns with dividends
DBVT4/6
Risk & VolatilityBeta, volatility, and downside exposure
QIPT2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
DBVT leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
QIPT and DBVT operate at a comparable scale, with $287M and $0 in trailing revenue.
| Metric | QIPTQuipt Home Medica… | DBVTDBV Technologies … |
|---|---|---|
| RevenueTrailing 12 months | $287M | $0 |
| EBITDAEarnings before interest/tax | $46M | -$112M |
| Net IncomeAfter-tax profit | -$11M | -$168M |
| Free Cash FlowCash after capex | $27M | -$151M |
| Gross MarginGross profit ÷ Revenue | +84.5% | — |
| Operating MarginEBIT ÷ Revenue | -0.8% | — |
| Net MarginNet income ÷ Revenue | -3.7% | — |
| FCF MarginFCF ÷ Revenue | +9.3% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | +34.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +2.8% | +91.5% |
DBVT leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
Evenly matched — QIPT and DBVT each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | QIPTQuipt Home Medica… | DBVTDBV Technologies … |
|---|---|---|
| Market CapShares × price | $161M | $1712.35T |
| Enterprise ValueMkt cap + debt − cash | $267M | $1712.35T |
| Trailing P/EPrice ÷ TTM EPS | -14.60x | -0.76x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 6.37x | — |
| Price / SalesMarket cap ÷ Revenue | 0.66x | — |
| Price / BookPrice ÷ Book value/share | 1.41x | 0.66x |
| Price / FCFMarket cap ÷ FCF | 6.34x | — |
Evenly matched — QIPT and DBVT each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
QIPT leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
QIPT delivers a -9.5% return on equity — every $100 of shareholder capital generates $-10 in annual profit, vs $-130 for DBVT. DBVT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to QIPT's 1.06x.
| Metric | QIPTQuipt Home Medica… | DBVTDBV Technologies … |
|---|---|---|
| ROE (TTM)Return on equity | -9.5% | -130.2% |
| ROA (TTM)Return on assets | -5.3% | -89.0% |
| ROICReturn on invested capital | -1.4% | — |
| ROCEReturn on capital employed | -1.8% | -145.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 |
| Debt / EquityFinancial leverage | 1.06x | 0.13x |
| Net DebtTotal debt minus cash | $7M | -$172M |
| Cash & Equiv.Liquid assets | $13M | $194M |
| Total DebtShort + long-term debt | $119M | $22M |
| Interest CoverageEBIT ÷ Interest expense | -0.30x | -189.82x |
QIPT leads this category, winning 4 of 7 comparable metrics.
Total Returns (Dividends Reinvested)
DBVT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in QIPT five years ago would be worth $5,497 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs QIPT's +70.6%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs QIPT's -16.1% — a key indicator of consistent wealth creation.
| Metric | QIPTQuipt Home Medica… | DBVTDBV Technologies … |
|---|---|---|
| YTD ReturnYear-to-date | +3.4% | +4.9% |
| 1-Year ReturnPast 12 months | +70.6% | +110.4% |
| 3-Year ReturnCumulative with dividends | -40.9% | +19.7% |
| 5-Year ReturnCumulative with dividends | -45.0% | -69.1% |
| 10-Year ReturnCumulative with dividends | +351.7% | -87.0% |
| CAGR (3Y)Annualised 3-year return | -16.1% | +6.2% |
DBVT leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
QIPT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
QIPT is the less volatile stock with a -0.03 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. QIPT currently trades 100.0% from its 52-week high vs DBVT's 76.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | QIPTQuipt Home Medica… | DBVTDBV Technologies … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.03x | 1.26x |
| 52-Week HighHighest price in past year | $3.65 | $26.18 |
| 52-Week LowLowest price in past year | $1.35 | $7.53 |
| % of 52W HighCurrent price vs 52-week peak | +100.0% | +76.3% |
| RSI (14)Momentum oscillator 0–100 | 76.6 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 594K | 252K |
QIPT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates QIPT as "Buy" and DBVT as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 0.0% for QIPT (target: $4).
| Metric | QIPTQuipt Home Medica… | DBVTDBV Technologies … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $3.65 | $46.33 |
| # AnalystsCovering analysts | 2 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
DBVT leads in 2 of 6 categories (Income & Cash Flow, Total Returns). QIPT leads in 2 (Profitability & Efficiency, Risk & Volatility). 1 tied.
Best OverallQuipt Home Medical Corp. (QIPT)Leads 2 of 6 categories
Loading custom metrics...
QIPT vs DBVT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is QIPT or DBVT a better buy right now?
Analysts rate Quipt Home Medical Corp.
(QIPT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — QIPT or DBVT?
Over the past 5 years, Quipt Home Medical Corp.
(QIPT) delivered a total return of -45. 0%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: QIPT returned +351. 7% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — QIPT or DBVT?
By beta (market sensitivity over 5 years), Quipt Home Medical Corp.
(QIPT) is the lower-risk stock at -0. 03β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately -3714% more volatile than QIPT relative to the S&P 500. On balance sheet safety, DBV Technologies S. A. (DBVT) carries a lower debt/equity ratio of 13% versus 106% for Quipt Home Medical Corp. — giving it more financial flexibility in a downturn.
04Which is growing faster — QIPT or DBVT?
On earnings-per-share growth, the picture is similar: Quipt Home Medical Corp.
grew EPS -56. 3% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — QIPT or DBVT?
DBV Technologies S.
A. (DBVT) is the more profitable company, earning 0. 0% net margin versus -4. 4% for Quipt Home Medical Corp. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DBVT leads at 0. 0% versus -1. 6% for QIPT. At the gross margin level — before operating expenses — QIPT leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — QIPT or DBVT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is QIPT or DBVT better for a retirement portfolio?
For long-horizon retirement investors, Quipt Home Medical Corp.
(QIPT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 03), +351. 7% 10Y return). Both have compounded well over 10 years (QIPT: +351. 7%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between QIPT and DBVT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.